Search

everythinglearnresearchcommunity

for

Search:↓

Post-finasteride syndrome causes lasting sexual, neurological, and physical side effects in some people after taking finasteride.

Finasteride can cause sexual problems and depression in young men.

Genetic counselors should be culturally skilled and aware of transgender patients' unique health risks and needs.

Finasteride may cause lasting sexual, mental, and physical symptoms; use with caution.

Hair and scalp pain is more common and severe in breast cancer patients on chemotherapy than those on tamoxifen.

Finasteride for hair loss may cause lasting sexual, genitourinary, mental, and anti-androgenic side effects in young men.

Post-finasteride syndrome's existence is uncertain; more research needed.

The document concludes that Hilary Mantel's memoir shows how childhood experiences affect adult health, criticizing modern medicine for ignoring the mental aspects of physical illness.

Many Chinese patients lose hair after weight loss surgery, especially women, and taking iron and zinc on their own doesn't help.

Trichotillomania treatment is most successful with a mix of behavioral therapy, medication, and social support.

5-alpha reductase inhibitors, like finasteride and dutasteride, may cause depression, but more research is needed to understand why.

Trichotillomania is a chronic condition where people uncontrollably pull out their hair, often starting in childhood.

Plica neuropathica can be a sign of schizophrenia and improves with antipsychotic treatment.

Antidepressants may improve or resolve scalp dysesthesia in most patients.

Trichotillomania, a disorder where people compulsively pull out their own hair, often starts around age 12, is more common in adult females, and can be treated with behavior therapy and medication.

Cyproterone acetate treatment is safe and causes mild feminization, which increases with added estrogen.

The conclusion is that in the Indian subcontinent, socioeconomic status, stress, and family structure affect the severity of alopecia areata, and its psychological impact is generally mild or moderate.

Mindfulness reduces anxiety and depression in skin disease patients; dermatologists and psychiatrists often lack confidence in treating psychodermatological conditions.

Trichotillomania was successfully treated with risperidone and naltrexone.

Low Vitamin D is common in people with Alopecia Areata, but its impact on the condition needs more research.

Impulsiveness is common across various psychiatric disorders and linked to many psychological symptoms.

A man developed a rare late-onset hair-pulling disorder, usually seen in younger people.

Women with PCOS often experience anxiety, depression, and a lower quality of life.

A woman's hair loss during Hepatitis C treatment with PEG-INF-a-2a and Ribavirin was reversible after stopping the medication.

Excessive hair growth affects the quality of life of Iranian women with PCOS the most.

Inositol was not more effective than a placebo in treating trichotillomania.

Longer CAG and GGN repeats increase alopecia risk, but no significant link to post-finasteride syndrome found.

Patients treated in Respiratory Intensive Care Units for COVID-19 are more likely to get mood disorders than those in other care settings.

PCOS is a common hormonal disorder in women that can be managed with lifestyle changes and various medications.

The conclusion is that obesity should be managed with a slow, balanced approach to diet and exercise, with medication and surgery as additional options, and education and access to care are important.